中金:預計交通銀行、泡泡瑪特、百勝中國、京東物流等或可“染藍”
中金髮表報告表示,恆生指數公司將於8月22日收市後公佈恆生系列指數半年度審議結果(審議考察截止日期爲今年6月30日),涉及恆生、國企、恆生科技等港股主要旗艦指數,以及與港股通投資範圍密切相關的恆生綜指。由於半年度審議通常變化較大,且追蹤旗艦指數的被動資金規模大(綜合彭博與Wind的統計,追蹤恆指、國企和恆生科技指數的ETF規模分別約爲303.5億美元、66.3億美元和261.2億美元),因此潛在成分股變動以及相應資金流向值得重點關注。基於恆生指數調整方法,並通過此前多次實際調整結果對非量化主觀調整標準的理解和驗證,該行估算交通銀行、泡泡瑪特、百勝中國、小鵬汽車、華住集團、京東物流與信達生物等排在恆生指數順位前列,有可能成爲納入的潛在候選者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.